Research Paper Volume 15, Issue 21 pp 12136—12154
Multi-omics analysis reveals PUS1 triggered malignancy and correlated with immune infiltrates in NSCLC
Figure 4. High expression of PUS1 promotes NSCLC development. (A) Based on the TCGA-LUAD and LUSC data, the expression of PUS1 was analyzed across the main pathological stages (stage I, II, III, and IV); (B, C) The correlation of PUS1 expression with different T stages in NSCLC based on the GSE30219 and GSE68465; (D) The correlation of PUS1 expression with different N stages in NSCLC is based on the GSE30219; (E, F) The correlation of PUS1 expression with different pathological stages in NSCLC is based on the GSE5852 and GSE31210; (G–J) The correlation of PUS1 expression with different differentiation in NSCLC is based on the GSE31547, GSE43580, GSE68465, and GSE103512. *P < 0.05, **P < 0.01, ***P < 0.001.